FACESurg: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FACESurg
Largest movements
- Cash +€209,745
up €209,745 (+98.0%), from €213,937 to €423,682
mainly Net result for the year (+€399,774) and Other debts (+€11,217)
- Receivables within one year +€51,851
up €51,851 (+64.7%), from €80,081 to €131,932
of which Trade receivables: +€45,917
- Current investments +€9,428
up €9,428 (+3.1%), from €300,000 to €309,428
- Profit (loss) carried forward +€398,941
up €398,941 (+95.9%), from €415,968 to €814,909
- Tax, wage and social debts -€138,961
down €138,961 (-92.4%), from €150,465 to €11,504
of which Taxes: -€138,961
- Other debts +€11,217
up €11,217 (+42.1%), from €26,643 to €37,860
- Gross operating margin -€29,090
down €29,090 (-5.3%), from €551,384 to €522,294
- Financial income +€8,618
up €8,618 (+2127.9%), from €405 to €9,023
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €595,076 | €866,273 | +€271,197 | +45.6% |
| Current assets | 29/58 | €595,076 | €866,273 | +€271,197 | +45.6% |
| Amounts receivable within one year | 40/41 | €80,081 | €131,932 | +€51,851 | +64.7% |
| Trade receivables | 40 | €80,081 | €125,998 | +€45,917 | +57.3% |
| Other amounts receivable | 41 | - | €5,934 | +€5,934 | |
| Current investments | 50/53 | €300,000 | €309,428 | +€9,428 | +3.1% |
| Cash at bank and in hand | 54/58 | €213,937 | €423,682 | +€209,745 | +98.0% |
| Deferred charges and accrued income | 490/1 | €1,058 | €1,231 | +€173 | +16.4% |
| Total equity and liabilities | 10/49 | €595,076 | €866,273 | +€271,197 | +45.6% |
| Equity | 10/15 | €417,968 | €816,909 | +€398,941 | +95.4% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €415,968 | €814,909 | +€398,941 | +95.9% |
| Amounts payable | 17/49 | €177,108 | €49,364 | -€127,744 | -72.1% |
| Amounts payable within one year | 42/48 | €177,108 | €49,364 | -€127,744 | -72.1% |
| Taxes, remuneration and social security | 45 | €150,465 | €11,504 | -€138,961 | -92.4% |
| Taxes | 450/3 | €147,135 | €8,174 | -€138,961 | -94.4% |
| Remuneration and social security | 454/9 | €3,330 | €3,330 | = | 0.0% |
| Other amounts payable | 47/48 | €26,643 | €37,860 | +€11,217 | +42.1% |
| Other operating charges | 640/8 | €427 | €417 | -€10 | -2.4% |
| Gross operating margin | 9900 | €551,384 | €522,294 | -€29,090 | -5.3% |
| Operating profit (loss) | 9901 | €550,957 | €521,877 | -€29,080 | -5.3% |
| Financial income | 75/76B | €405 | €9,023 | +€8,618 | +2127.9% |
| Recurring financial income | 75 | €405 | €9,023 | +€8,618 | +2127.9% |
| Financial charges | 65/66B | - | €2,061 | +€2,061 | |
| Recurring financial charges | 65 | - | €2,061 | +€2,061 | |
| Profit (loss) for the period before taxes | 9903 | €551,362 | €528,840 | -€22,522 | -4.1% |
| Income taxes | 67/77 | €134,535 | €129,066 | -€5,469 | -4.1% |
| Profit (loss) for the period | 9904 | €416,827 | €399,774 | -€17,053 | -4.1% |
| Profit (loss) for the period to be appropriated | 9905 | €416,827 | €399,774 | -€17,053 | -4.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.